Today's Hours: 8:00am - 10:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Journal
    Digital Access
    Provider
    Version
    TandFonline
    v. 1-105, 1907-2011.
    HathiTrust
    v. 1-16, 1907/08-1922.
    Acad Search Prem
    v. 91-102, 1997-2008.
    Print Access
    Location
    Version
    Call Number
    Items
    Periodicals (Downstairs)
    v. 1-95, 1907-2001.
    SHELVED UNDER: Annals of tropical medicine.
    93
    Request
    Stored offsite. Please request print.
    v. 96-102, 2002-11.
    13
    Request
  • Article
    Doongaji DR, Sheth A, Apte JS, Lakdawala PD, Khare CB, Thatte SS.
    J Clin Pharmacol. 1978 Jul;18(7):358-64.
    Clobazam, a new antianxiety compound, was compared in a double-blind study with diazepam in 40 neurotic outpatients. Twenty-three patients completed the trial under clobazam conditions while 17 patients completed the trial under diazepam conditions. The trial was conducted for a period of four weeks of active drug administration followed by a one-week period of placebo administration. Clobazam was administered in three divided doses of 30 to 40 mg/day, while diazepam was administered in three divided doses of 15 to 20 mg/day, following a fixed dosage schedule. No significant differences were noted between the two treatment conditions during the drug trial period. The patients on clobazam maintained greater improvement during the placebo trial period for the variables "somatic anxiety" and "nights of sleep disturbance." Simultaneous motor coordination tests (hand steadiness test) showed greater improvement on clobazam throughout the trial period in patients with an initial error score greater than 50 points. This difference was significant during the second week of the trial.
    Digital Access Access Options